Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients

Therapeutics and Clinical Risk Management

Volumn 3, Issue 5, 2007, Pages 961-967

  Villesen, Hanne H ^a   Banning, Anne Marie ^b   Petersen, Rasmus H ^c   Weinelt, Sebatian ^c   Poulsen, Jesper B ^c   Hansen, Steen H ^a   Christrup, Lona L ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c University of Esbjerg   (Denmark)

Author keywords

Age; Elderly; Morphine; Oxycodone; Pharmacokinetics

Indexed keywords

MORPHINE; OXYCODONE; OXYNORM; UNCLASSIFIED DRUG;

AGED; ANALGESIA; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; ELECTIVE SURGERY; FEMALE; GERIATRIC SURGERY; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; TOTAL HIP PROSTHESIS;

EID: 36448976943     PISSN: 11766336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Aitkenhead AR, Vater M, Achola K, et al. 1984. Pharmacokinetics of a single-dose i.v. morphine in normal volunteers and patients with end-stage renal failure. British Journal of Anaesthesia, 56:813-9.
2. Baillie SP, Bateman DN, Coates PE, et al. 1989, Age and the pharmacokinetics of morphine. Age and Ageing, 18:258-62.
3. Bellville JW, Forrest WH, Miller E, et al. 1971. Influence of age on pain relief from analgesics. JAMA, 217:1835-41.
4. Berkowitz BA, Ngai SH, Yang JC, et al. 1975. The disposition of morphine in surgical patients, Clinical Pharmacology and Therapeutics, 17:629-35.
5. Chauvin M, Sandouk P, Scherrmann J-M, et al. 1987. Morphine pharmacokinetics in renal failure. Anesthesiology, 66:327-31.
6. Gibson SJ, Weiner DK. 2005. Pain in older persons. Seattle, USA: IASP Press.
7. Hasselström J, Säwe J. 1993. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Clinical Pharmacokinetics, 24:344-54.
8. Kaiko RF. 1980. Age and morphine analgesia in cancer patients with postoperative pain. Clinical Pharmacology and Therapeutics, 28:823-6.
9. Kirvela M, Lindgren L, Seppala T, et al. 1996. The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation. Journal of Clinical Anesthesia, 8:13-8.
10. Klepstad P, Dale O, Skorpen F, et al. 2005. Genetic variability and clinical efficacy of morphine. Acta Anaesthesiol Scand, 49:902-8.
11. Klepstad P, Rakvag TT, Kaasa S, et al. 2004. The 118 A > G polymorphism in the human micro-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand, 48:1232-9.
12. Leow KP, Cramond T, Smith MT. 1995. Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain. Anesthesia and Analgesia, 80:296-302.
13. Leow KP, Smith MT, Watt JA, et al. 1992. Comparative oxycodone pharmacokinetics in humans after intravenous, oral, and rectal administration. Therapeutic Drug Monitoring, 14:479-84.
14. Leow KP, Smith MT, Williams B, et al. 1992. Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer. Clinical Pharmacology and Therapeutics, 52:487-95.
15. Mazoit J-X, Sandouk P, Zetlaoui P, et al. 1987. Pharmacokinetics of unchanged morphine in normal mid cirrhotic subjects. Anesthesia Analgesia, 66:293-8.
16. Moore A, Sear J, Baldwin D, et al. 1984. Morphine kinetics during and after renal transplantation. Clinical Pharmacology and Therapeutics, 35:641-5.
17. Murphy MR, Hug Jr CC. 1981. Pharmacokinetics of intravenous morphine in patients anesthetized with enflurane-nitrous oxide. Anesthesiology, 54:187-92.
18. Owen JA, Sitar DS, Berger L, et al. 1983. Age-related morphine kinetics. Clinical Pharmacology and Therapeutics, 34:364-8.
19. Patwardhan RV, Johnson RF, Hoyumpa A, et al. 1981. Normal metabolism of morphine in cirrhosis. Gastroenterology, 81:1006-11.
20. Pöyhiä R, Hynynen M, Seppala T, et al. 2004. Pharmacodynamics and pharmacokinetics of high-dose oxycodone infusion during and after coronary artery bypass grafting. Journal of Cardiothoracic and Vascular Anesthesia, 18:748-54.
21. Pöyhiä R, Olkkola KT, Seppala T, et al. 1991. The pharmacokinetics of oxycodone after intravenous injection in adults. British Journal of Clinical Pharmacology, 32:516-8.
22. Romberg R, Olofsen E, Sarton E, et al. 2004, Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers. Anesthesiology, 100: 120-33.
23. Romberg R, Olofsen E, Taschner PEM, et al. 2005. Polymorphism of mu-opioid receptor gene (OPRM1:c. 118A > G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. Anesthesiology, 102:522-30.
24. Rowland M, Tozer TN. 1995. Clinical pharmacokinetics, concepts and applications, 3rd edn. Philidelphia: Lippincott Williams & Wilkins.
25. Säwe J, Dahlstrom B, Paalzow L, et al. 1981. Morphine kinetics in cancer patients. Clinical Pharmacology and Therapeutics, 30:629-35.
26. Säwe J, Odar-Cederlöf I. 1987. Kinetics of morphine in patients with renal failure. European Journal of Pharmacology, 32:377-82.
27. Saywer MB, Innocenti F, Das S, et al. 2003. A pharmacogentic study of uridine diphosphate-glucuronosyltranferase 2B7 in patients receiving morphine. Clinical Pharmacology and Therapeutics, 73:566-74.
28. Sear JW, Hand CW, Moore RA. 1989. Studies on morphine disposition: plasma concentrations of morphine and its metabolites in anesthetized middle-aged and elderly surgical patients. Journal of Clinical Anesthesia, 1:164-9.
29. Sear JW, Hand CW, Moore RA, et al. 1989a. Studies on morphine disposition: Influence of general anaesthesia on plasma concentrations of morphine and its metabolites. British Journal of Anaesthesia, 62:22-7.
30. Sear JW, Hand CW, Moore RA, et al. 1989b. Studies on morphine disposition: Influence of renal failure on the kinetics of morphine and its metabolites. British Journal of Anaesthesia, 62:28-32.
31. Stanski DR, Greenblatt DJ, Lappas DG, et al. 1976. Kinetics of high-dose ontraveneous morphine in cardiac surgery patients. Clinical Pharmacology and Therapeutics, 19:752-6.
32. Stanski DR, Greenblatt DJ, Lowenstein E. 1978. Kinetics of intravenous and intramuscular morphine. Clinical Pharmacology and Therapeutics, 24:52-9.
33. Stuart-Harris R, Joel SP, MeDonald P, et al. 2000. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous injection and subcutaneous infusion of morphine. British Journal of Clinical Pharmacology, 49:207-14.
34. Tallgren M, Olkkola KT, Seppala T, et al. 1997. Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation. Clinical Pharmacology and Therapeutics, 61:655-61.
35. Westerling D, Frigren L, Höglund P. 1993. Morphine Pharmacokinetics and Effects on Salivation and Continuous Reaction Times in Healthy Volunteers. Therapeutic Drug Monitoring, 15:364-74.
36. Westerling D, Höglund P, Lundin S, et al. 1994. Transdermal administration of morphine to healthy subjects. British Journal of Clinical Pharmacology, 37:571-6.
37. Westerling D, Persson C, Höglund P. 1995. Plasma Concentrations of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide After Intravenous and Oral Administration to healthy Volunteers: Relationship to nonanalgesic Action. Therapeutic Drug Monitoring, 17:287-301.